July 28, 2016
PathMaker Neurosystems Inc. recently announced it was named as a finalist for the Innovation Prize 2016. According to a press release, the global award was founded by Universal Biotech and recognizes innovative startups and research academic groups that are “developing cutting-edge technologies in the field of life sciences.”
PathMaker is one of six finalists chosen from 259 entrants from 38 countries. According to the release, finalists were selected based on scientific quality of the innovation, intellectual property, quality of the human resources, project feasibility and market access strategy. The jury includes experts from major health care companies, pharmaceutical companies, biotechnology societies and legal firms with experience reviewing new technologies. PathMaker was chosen for its noninvasive systems that treat patients with neural pathway disruptions, such as stroke, cerebral palsy, multiple sclerosis, Parkinson’s disease, traumatic brain injury and spinal cord injury.